Insights

Perspectives on antibody discovery and developability.

Short reads from our team on shifting developability upstream, AI-driven triage, and what we are learning across modalities.

[ Insight ]

Antibody Characterization by Liquid Chromatography and Mass Spectrometry (LC-MS/MS)

Comprehensive LC-MS/MS workflows — intact mass, subunit mass, peptide mapping, glycosylation, and sequence variant analysis — for antibody quality control, developability assessment, and production optimization.

2026

[ Insight ]

Triaging Diverse Antibody Candidates

Triaging diverse antibody candidates enables efficient triage of antibody therapeutics against a target of interest using both in vitro and in silico properties to prioritize the best candidates and reduce bench workload.

2026

[ Insight ]

Why Early Antibody Developability Assessment Matters?

Discover why early antibody developability assessment is critical for identifying liabilities, reducing development risk, improving candidate selection, and accelerating therapeutic success.

2026